1. Sheiner LB, Steimer JL. Pharmacokinetic/pharmacodynamic modeling in drug development.Annu Rev Pharmacol Toxicol. 2000;40:67–95.
2. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Food and Drug Administration. Guidance for Industry.Exposure-Response Relationships—Study Design, Data Analysis, and Regulatory Applications. Rockville, MD: Food and Drug Administration, 2003.
3. Sheiner LB. Learning versus confirming in clinical drug development.Clin Pharmacol Ther. 1997;61:275–291.
4. Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Food and Drug Administration. Guidance for Industry.Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products. Rockville, MD: Food and Drug Administration, 1999.
5. The US Congress. The Federal Food, Drug, and Cosmetic Act, as amended in 1962. Pub. L. No. 87-781, 76 Stat. 780. 1962.